Moreover, in the PD mice model, EPA-PL improved behavioral deficiency by suppressing oxidative stress and apoptosis, thereby alleviating the loss of DA neurons via the mitochondria-mediated pathway and mitogen-activated protein kinase pathway [36]. The gene discussed is WNK2; the disease is Parkinson disease.